Pharmacokinetics News and Research

RSS
The term pharmacokinetics is derived from the ancient Greek words “pharmakon” and “kinetikos”, meaning “drug” and “putting in motion” respectively. It is one of the main branches of pharmacology, and refers to the way that the body reacts on and affects a pharmaceutical substance in the body.

Further Reading

Minoryx Therapeutics initiates phase 1 clinical trial of MIN-102

Minoryx Therapeutics initiates phase 1 clinical trial of MIN-102

Article reviews impact of adding pyridine based antitumor compounds at colchicine site

Article reviews impact of adding pyridine based antitumor compounds at colchicine site

Inhalable ibuprofen holds potential to treat cystic fibrosis

Inhalable ibuprofen holds potential to treat cystic fibrosis

Study examines how gender and FH may affect alcohol use in adolescents

Study examines how gender and FH may affect alcohol use in adolescents

Novel imaging technique may assist surgeons to improve visualization of ovarian tumors during surgery

Novel imaging technique may assist surgeons to improve visualization of ovarian tumors during surgery

Topical delivery of AVR drug combination can provide complete protection against HIV

Topical delivery of AVR drug combination can provide complete protection against HIV

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Scientists provide overview of most promising compounds to combat prostate cancer

Scientists provide overview of most promising compounds to combat prostate cancer

BioAgilytix announces acquisition of IPM Biotech

BioAgilytix announces acquisition of IPM Biotech

Biomarkers may provide novel approaches to monitoring immunosuppressive therapy in organ transplant patients

Biomarkers may provide novel approaches to monitoring immunosuppressive therapy in organ transplant patients

Rutgers' new drug candidate may help fight malaria

Rutgers' new drug candidate may help fight malaria

Xencor begins XmAb5871 Phase 2 trials in patients with IgG4-RD and Systemic Lupus Erythematosus

Xencor begins XmAb5871 Phase 2 trials in patients with IgG4-RD and Systemic Lupus Erythematosus

New drug shows promise against Huntington's disease

New drug shows promise against Huntington's disease

Regulus reports net loss of $7.2 million for fourth quarter 2015

Regulus reports net loss of $7.2 million for fourth quarter 2015

AMRI's net revenues increase $126.4M to 46% in fourth quarter 2015

AMRI's net revenues increase $126.4M to 46% in fourth quarter 2015

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Ambrisentan avoids sildenafil drug interaction in PAH patients

Ambrisentan avoids sildenafil drug interaction in PAH patients

Molecular imaging and radiochemistry: the importance of instrumentation. An interview with Professor Björn Wängler

Molecular imaging and radiochemistry: the importance of instrumentation. An interview with Professor Björn Wängler

MabVax receives FDA authorization to initiate 89Zr-HuMab-5B1 Phase I trial in pancreatic cancer patients

MabVax receives FDA authorization to initiate 89Zr-HuMab-5B1 Phase I trial in pancreatic cancer patients

AbbVie doses first subject in adalimumab clinical trial using Halozyme's ENHANZE technology

AbbVie doses first subject in adalimumab clinical trial using Halozyme's ENHANZE technology